RT Journal Article
SR Electronic
T1 Improved deep learning model for differentiating novel coronavirus pneumonia and influenza pneumonia
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.03.24.20043117
DO 10.1101/2020.03.24.20043117
A1 Zhou, Min
A1 Chen, Yong
A1 Yang, Dexiang
A1 Xu, Yanping
A1 Yao, Weiwu
A1 Huang, Jingwen
A1 Jin, Xiaoyan
A1 Pan, Zilai
A1 Tan, Jingwen
A1 Wang, Lan
A1 Xia, Yihan
A1 Zou, Longkuan
A1 Xu, Xin
A1 Wei, Jingqi
A1 Guan, Mingxin
A1 Feng, Jianxing
A1 Zhang, Huan
A1 Qu, Jieming
YR 2020
UL http://medrxiv.org/content/early/2020/03/30/2020.03.24.20043117.abstract
AB Background Chest CT had high sensitivity in diagnosing novel coronavirus pneumonia (NCP) at early stage, giving it an advantage over nucleic acid detection in time of crisis. Deep learning was reported to discover intricate structures from clinical images and achieve expert-level performance in medical image analysis. To develop and validate an integrated deep learning framework on chest CT images for auto-detection of NCP, particularly focusing on differentiating NCP from influenza pneumonia (IP).Methods 35 confirmed NCP cases were consecutively enrolled as training set from 1138 suspected patients in three NCP designated hospitals together with 361 confirmed viral pneumonia patients from center one including 156 IP patients, from May, 2015 to February, 2020. The external validation set enrolled 57 NCP patients and 50 IP patients from eight centers.Results 96.6% of NCP lesions were larger than 1 cm and 76.8% were with intensity below –500 Hu, indicating less consolidation than IP lesions which had nodules ranging 5-10 mm. The classification schemes accurately distinguished NCP and IP lesions with area under the receiver operating characteristic curve (AUC) above 0.93. The Trinary scheme was more device-independent and consistent with specialists than the Plain scheme, which achieved a F1 score of 0.847, higher than the Plain scheme (0.774), specialists (0.785) and residents (0.644).Conclusions Our study potentially provides an accurate early diagnosis tool on chest CT for NCP with high transferability, and shows high efficiency in differentiating NCP and IP, helping to reduce misdiagnosis and contain the pandemic transmission.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded by National Key R&D Program of China (2017YFC1309701 and 2017YFC1309700), Shanghai Key Discipline for Respiratory Diseases (2017ZZ02014) and Shanghai Science and Technology Committee (18411953000). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesDue to patient privacy concerns the datasets are currently not publicly available. However, the datasets analyzed during the current study are available from the corresponding author on reasonable request.